Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia
Blood - United States
doi 10.1182/blood-2019-01-896290
Full Text
Open PDFAbstract
Available in full text
Date
June 27, 2019
Authors
Publisher
American Society of Hematology